Showing results (1321-1330 of 1,462) with videos related to

Sort By:
Pageof 147
American Journal of Human Genetics|June 28, 2000
SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer diseaseE R Martin, E H Lai, J R Gilbert, et al.
Neuro-Oncology|March 14, 2020
A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastomaVinay K Puduvalli, Jing Wu, Ying Yuan, et al.
Neuro-Oncology|May 28, 2025
Glioblastoma-enriched glycosphingolipids modulate the function of human iNKT cellsMorgan J Coombs, Tyrone Dowdy, Md Masud Alam, et al.
Journal of Neuro-Oncology|October 19, 2015
A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patientsJ J Raizer, P Giglio, J Hu, et al.
Neurology. Genetics|April 12, 2016
Segregation of a rare TTC3 variant in an extended family with late-onset Alzheimer diseaseMartin A Kohli, Holly N Cukier, Kara L Hamilton-Nelson, et al.
Neuro-Oncology|April 29, 2017
An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825Haley Gittleman, Daniel Lim, Michael W Kattan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2010
Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working groupPatrick Y Wen, David R Macdonald, David A Reardon, et al.
Neurosurgery|September 7, 2018
Cytokine Microdialysis for Real-Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint BlockadeJohn Lynes, Sadhana Jackson, Victoria Sanchez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2013
Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trialMark R Gilbert, Meihua Wang, Kenneth D Aldape, et al.
Neuro-Oncology|February 13, 2010
A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapyJeffrey J Raizer, Lauren E Abrey, Andrew B Lassman, et al.
Pageof 147